159
Participants
Start Date
May 31, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
GTx-024
1 mg GTx 024
GTx-024
3 mg GTx-024
Placebo
Matching Placebo
Urological Associates of Lancaster, Lancaster
Consultants in Medical Oncology and Hematology, Drexel Hill
Berks Hematology-Oncology Associates, West Reading
Center for Cancer & Blood Disorders, Bethesda
Johns Hopkins University Clinical Trial Unit, Baltimore
The Center for Clinical Research WA County Hospital, Hagerstown
Hanover Medical Specialists, Wilmington
Four Seasons Hospice & Palliative Care, Flat Rock
Cancer Care of Western North Carolina, Ashville
Charleston Hematology Oncology Associates, Charleston
Augusta Oncology Associates, Augusta
Dublin Hematology and Oncology, Dublin
Gainesville Hematology Oncology Associates, Gainesville
Osler Medical, Melbourne
Horizon Institute for Clinical Research, Hollywood
Innovative Medical Research of South Florida, Inc., Miami
Hematology Oncology Associates, Lake Worth
The Radiation Oncology Group, Lake Worth
Florida Medical Clinic, PA, Zephyrhills
Watson Clinic LLP, Center for Cancer Care & Research, Lakeland
West Clinic, Memphis
West Clinic, Memphis
The West Clinic, Southaven
West Clinic, Southaven
Hematology & Oncology Associates at Bridgeport, Tupelo
The West Clinic, Corinth
West Clinic, Corinth
Kentuckiana Cancer Institute, Louisville
Hematology Oncology Consultants, Worthington
Gabrail Cancer Center, Canton
Signal Point Clinical Research Center, LLC, Middletown
Newland Medical Center, Southfield
Donald H. Berdeaux, MD, FACP, PC, Great Falls
Great Falls Clinic, LLP - Clinic Cancer Care, Great Falls
Heartland Hematology-Oncology Associates, Kansas City
Cancer Center of Kansas, Wichita
Creighton University Hematology/Oncology Clinic, Omaha
Highlands Oncology Group, Fayetteville
Dallas Oncology Consultants, Dallas
Penrose Cancer Center, Colorado Springs
Dorcy Cancer Center, Pueblo
Desert Hematology Oncology Medical Group, Rancho Mirage
Compassionate Cancer Care, Riverside
Compassionate Cancer Care Medical Group, Fountain Valley
Pacific Coast Hematology/Oncology Medical Group, Inc., Fountain Valley
Compassionate Cancer Care, Corona
Providence Everett Medical Center, Cancer Research Department, Everett
Alaska Cancer Research and Education Center, Anchorage
Hartford Hospital Cancer Clinical Research Office, Hartford
Medical Oncology & Hematology, PC, Waterbury
University of Alberta Cross Cancer Institute, Edmonton
Princess Margaret Hospital, Toronto
Lead Sponsor
GTx
INDUSTRY